Macaire C, Lefevre W, Dalac S, Montaudie H, et al. Real-life effectiveness on overall survival of continued immune checkpoint inhibition following progression in advanced melanoma: estimation from the Melbase cohort. Melanoma Res 2024 Nov 11. doi: 10.1097/CMR.0000000000000973.
PMID: 39527777